Biocorp Production Stock

Biocorp Production EBIT

Delisted

The EBIT of Biocorp Production (ALCOR.PA) as of Aug 13, 2026 is -848,837.00 EUR. In the previous year, EBIT was 137,408.00 EUR — a change of -717.75% (lower).

EBIT

-848,837.00EUR

YoY

-717.75%

Last updated:

In 2026, Biocorp Production's EBIT was -848,837.00 EUR, a -717.75% increase from the 137,408.00 EUR EBIT recorded in the previous year.

The Biocorp Production EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2019
0.88 base
Jan 1, 2020
-1.61 base
Jan 1, 2021
0.14 base
Jan 1, 2022
-0.85 base
Jan 1, 2023 (e)
0.77 base
Jan 1, 2024 (e)
2.47 base
Jan 1, 2025 (e)
4.12 base
Jan 1, 2026 (e)
49.65 base
YEAREBIT (M EUR)
2026 est 49.65
2025 est 4.12
2024 est 2.47
2023 est 0.77
2022 -0.85
2021 0.14
2020 -1.61
2019 0.88
2018 -5.27
2017 -7.87
2016 -4.65
2015 -2.94
2014 -2.57
2013 -1.64
2012 -0.29
Access this data via the Eulerpool API

Biocorp Production Revenue

Biocorp Production Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
8.45 M EUR
875,017.00 EUR
959,781.00 EUR
Jan 1, 2020
8.46 M EUR
-1.61 M EUR
-1.24 M EUR
Jan 1, 2021
10.23 M EUR
137,408.00 EUR
294,234.00 EUR
Jan 1, 2022
11.67 M EUR
-848,837.00 EUR
-651,180.00 EUR
Jan 1, 2023 (e)
14.70 M EUR
772,500.00 EUR
43,986.00 EUR
Jan 1, 2024 (e)
22.20 M EUR
2.47 M EUR
1.58 M EUR
Jan 1, 2025 (e)
29.97 M EUR
4.12 M EUR
3.72 M EUR
Jan 1, 2026 (e)
61.42 M EUR
49.65 M EUR
52.08 M EUR

Biocorp Production Margins

Biocorp Production stock margins

The Biocorp Production margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biocorp Production. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biocorp Production.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
60.01 %
10.36 %
11.36 %
Jan 1, 2020
42.76 %
-18.98 %
-14.69 %
Jan 1, 2021
58.68 %
1.34 %
2.88 %
Jan 1, 2022
50.89 %
-7.27 %
-5.58 %
Jan 1, 2023 (e)
50.89 %
5.26 %
0.30 %
Jan 1, 2024 (e)
50.89 %
11.14 %
7.13 %
Jan 1, 2025 (e)
50.89 %
13.75 %
12.39 %
Jan 1, 2026 (e)
50.89 %
80.84 %
84.80 %

Biocorp Production Stock analysis

What does Biocorp Production do? Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Biocorp Production's EBIT

Biocorp Production's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Biocorp Production's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Biocorp Production's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Biocorp Production’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Biocorp Production stock

EBIT of Biocorp Production is -848,837.00 EUR in 2026.

EBIT of Biocorp Production changed from 137,408.00 EUR to -848,837.00 EUR, representing a -717.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Biocorp Production since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Biocorp Production historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Biocorp Production

All Key Metrics — Biocorp Production